Page 4 - Movement Disorders Program News Today

STATEPOINT— When Ann Hanley was 49 years old, she noticed that she had persistent stiffness in her shoulders and her arms weren’t swinging norm

Alzheimer’s, Parkinson’s, and traumatic brain injury can cause changes in behavior by altering brain anatomy. Now it seems the coronavirus can too.

Although dopamine agonists and dopamine reuptake inhibitors (DRIs) may be effective in treating Parkinsons disease and motor fluctuations not controlled with levodopa, not all DRIs are equal.

(StatePoint) When Ann Hanley was 49 years old, she noticed that she had persistent stiffness in her shoulders and her arms weren’t swinging normally when she walked. This became particularly

When treating oromandibular dystonia with botulinum toxin injection to the lateral pterygoid muscle, an intraoral approach is the safest way to avoid injury to the maxillary artery, new research suggests.

App Enables Users to Track Brain Disorders on Their Smartphones App Enables Users to Track Brain Disorders on Their Smartphones Comments Off on App Enables Users to Track Brain Disorders on Their Smartphones BINYAMINA, Israel — People with chronic diseases are advised to stay home during the Covid-19 pandemic because they are at risk for complications should they become infected. However, that makes it difficult to get essential medical monitoring for their existing conditions. And while Isr...

Jan 13, 2021 Montfort’s FDA-cleared neurological monitoring is used by healthcare facilities on four continents and is tracking post-Covid symptoms in Brazil. By Abigail Klein Leichman, ISRAEL21c People with chronic diseases are advised to stay home during the Covid-19 pandemic because they are at risk for complications should they become infected. However, that makes it difficult to get essential medical monitoring for their conditions. And while Israel has emerged as a world leader in tele...

Share this article Share this article BINYAMINA, Israel, Dec. 16, 2020 /PRNewswire/ -- Montfort (Mon4t), an innovative medical startup introduces its real-time, remote neurological monitor. Montforts FDA-cleared solution leverages smartphone technology, big-data and AI to conduct digital neurological tests for patients with conditions such as Parkinsons disease, Huntingtons disease, psychiatric disorders (like schizophrenia), as well as for patients with Post-COVID19 symptoms, some of which ar...